Krazati monotherapy shows significant survival benefit in KRAS G12C-mutated NSCLC Phase III Krystal -12 data
The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
All claims against the company in the litigation have now been dismissed.
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
Subscribe To Our Newsletter & Stay Updated